Cancer Drug Reduces SIV Reservoir in Macaques, May Inform HIV Cure Strategies
Venetoclax, a cancer drug that inhibits BCL-2, reduced the intact SIV reservoir in macaques, offering preclinical support for targeting BCL-2 as part of HIV cure strategies.